Loading...
NPI 1245217751 · Jersey City, NJ · Internal Medicine Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Carl Restivo is a internal medicine physician provider located in Jersey City, New Jersey. This profile covers 6 Medicare and 17 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Carl Restivo |
| Address | 3 Webster Ave |
| City | Jersey City |
| State | NJ |
| ZIP | 07307 |
| Taxonomy | Internal Medicine Physician |
| NPI Enumerated | December 27, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $797.3K |
| Medicare | $30.6K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
6 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 240 | $70 | $15.9K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 120 | $80 | $9.5K |
| 20605 | In this procedure, the provider inserts a needle through the skin of a patient and into an intermediate joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may… | 50 | $50 | $2.6K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 20 | $140 | $2.3K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 60 | $10 | $280 |
| J9250 | Methotrexate sodium, 5 mg | 970 | $0 | $0 |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 6 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
17 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 9,290 | $40 | $343.6K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 8,920 | $40 | $338.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 410 | $80 | $34.4K |
| 96372 | A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician… | 2,360 | $10 | $21.3K |
| 20605 | In this procedure, the provider inserts a needle through the skin of a patient and into an intermediate joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may… | 450 | $20 | $10.7K |
| J9250 | Methotrexate sodium, 5 mg | 8,390 | $1 | $8.4K |
| 99244 | The provider sees a patient for an office or other outpatient consultation involving evaluation and management (E/M). The E/M involves a moderate level of medical decision making or the provider… | 80 | $110 | $8.3K |
| 73120 | X–rays of the extremities have been performed to assess injury, fracture, arthritis, bone spurs, tumors, or congenital abnormalities. Extremity X–rays include the hand, wrist, arm, foot, ankle, hip,… | 370 | $20 | $7K |
| 99245 | The provider sees a patient for an office or other outpatient consultation involving evaluation and management (E/M). The E/M involves a high level of medical decision making or the provider spends… | 50 | $140 | $6.5K |
| 73620 | In this diagnostic procedure, the provider takes two X–ray views of a patient’s foot to assess an injury, fracture, arthritis, tumor, or congenital abnormality. | 170 | $20 | $3.1K |
Showing 1–10 of 17
How this provider's Medicaid billing volume and revenue compare to other New Jersey providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New Jersey median
17 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 511 | 4,450 | 740 | $40 | $229.8K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 1 | 30 | 170 | $80 | $88.7K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 305 | 1,160 | 110 | $110 | $79.7K |
| 20610 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may inject a… | 90 | 120 | 240 | $50 | $60K |
| 99244 | The provider sees a patient for an office or other outpatient consultation involving evaluation and management (E/M). The E/M involves a moderate level of medical decision making or the provider… | 126 | 230 | 110 | $140 | $49K |
| 96372 | A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician… | 109 | 580 | 390 | $20 | $46.2K |
| 73030 | This particular procedure is for a minimum of 2 X–ray views of the complete shoulder. | 130 | 180 | 370 | $30 | $35.4K |
| 99245 | The provider sees a patient for an office or other outpatient consultation involving evaluation and management (E/M). The E/M involves a high level of medical decision making or the provider spends… | 30 | 60 | 60 | $150 | $29.4K |
| 73120 | X–rays of the extremities have been performed to assess injury, fracture, arthritis, bone spurs, tumors, or congenital abnormalities. Extremity X–rays include the hand, wrist, arm, foot, ankle, hip,… | 9 | 30 | 160 | $30 | $26K |
| 20605 | In this procedure, the provider inserts a needle through the skin of a patient and into an intermediate joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may… | 3 | 20 | 120 | $20 | $9.7K |
Showing 1–10 of 17
Other providers in the same ZIP code as Carl Restivo, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Hemant Shah | NJ | Family Medicine Physician | $208.9K | $0 |
| Ravi Rathi | NJ | Clinical Cardiac Electrophysiology Physician | $159.4K | $0 |
| Mark Granata | NJ | Foot & Ankle Surgery Podiatrist | $152.2K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.